BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32699683)

  • 1. Radioiodine Therapy-Induced Conversion of Toxic Adenoma to Graves' Disease.
    Rehman A; Obici S; Yaqub A
    Cureus; 2020 Jun; 12(6):e8683. PubMed ID: 32699683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely high doses of radioiodine required for treatment of Graves' hyperthyroidism: a case report.
    Neto AM; Tambascia MA; Brunetto S; Ramos CD; Zantut-Wittmann DE
    Cases J; 2009 Aug; 2():8479. PubMed ID: 19918435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report.
    Yürekli Y; Cengiz A; Güney E
    Mol Imaging Radionucl Ther; 2015 Oct; 24(3):135-7. PubMed ID: 27529890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
    Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
    Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
    Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
    J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of simultaneous occurrence of Marine - Lenhart syndrome and a papillary thyroid microcarcinoma.
    Scherer T; Wohlschlaeger-Krenn E; Bayerle-Eder M; Passler C; Reiner-Concin A; Krebs M; Gessl A
    BMC Endocr Disord; 2013 May; 13():16. PubMed ID: 23657056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
    Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
    Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
    J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
    Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
    J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves disease following radioiodine therapy for toxic adenoma: Clinical case report.
    Shen G; Cui F; Huang R; Kuang A
    Medicine (Baltimore); 2017 Nov; 96(45):e8550. PubMed ID: 29137069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A remarkable case of thyrotoxicosis initially caused by graves' disease followed by a probable TSHoma - a case report.
    Quinn M; Bashari W; Smith D; Gurnell M; Agha A
    BMC Endocr Disord; 2020 Aug; 20(1):133. PubMed ID: 32854689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DYNAMIC CHANGES OF TRAb AND TPOAb AFTER RADIOIODINE THERAPY IN GRAVES' DISEASE.
    Dong Q; Liu X; Wang F; Xu Y; Liang C; Du W; Gao G
    Acta Endocrinol (Buchar); 2017; 13(1):72-76. PubMed ID: 31149151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves Disease Following Subacute Thyroiditis in a Chinese Man.
    Al-Bacha S; Lahiri SW
    AACE Clin Case Rep; 2022; 8(2):73-77. PubMed ID: 35415228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.
    Sriphrapradang C; Bhasipol A
    Ann Med Surg (Lond); 2016 Sep; 10():69-72. PubMed ID: 27570620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
    Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
    Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' disease in the cervical thyroid and thyroglossal duct remnant: case report and review of literature.
    Buckingham H; Sauerwein TJ; Golding AC
    Endocr Pract; 2006; 12(4):401-5. PubMed ID: 16901795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant cardiac disease complicating Graves' disease in previously healthy young adults.
    Witczak JK; Ubaysekara N; Ravindran R; Rice S; Yousef Z; Premawardhana LD
    Endocrinol Diabetes Metab Case Rep; 2020 Jan; 2020():. PubMed ID: 31967967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of an autonomously functioning thyroid nodule in a patient with Graves' disease: an unusual presentation of Marine-Lenhart syndrome.
    Nishikawa M; Yoshimura M; Yoshikawa N; Toyoda N; Yonemoto T; Ogawa Y; Mori S; Tabata S; Tokoro T; Sakaguchi N; Inada M
    Endocr J; 1997 Aug; 44(4):571-4. PubMed ID: 9447292
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.